|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1996-10-31
|
|
pubmed:abstractText |
It is important to compare the incidence of bacterial contamination of components collected from the peripheral blood or bone marrow (BM), as well as of components processed with or without cell selection or depletion, and to evaluate the sequelae of such contamination.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0041-1132
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
782-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8823450-Antibodies, Monoclonal,
pubmed-meshheading:8823450-Antigens, CD34,
pubmed-meshheading:8823450-Bacterial Infections,
pubmed-meshheading:8823450-Bone Marrow Cells,
pubmed-meshheading:8823450-Bone Marrow Purging,
pubmed-meshheading:8823450-Freezing,
pubmed-meshheading:8823450-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:8823450-Humans,
pubmed-meshheading:8823450-Lymphocyte Depletion
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
|
|
pubmed:affiliation |
Blood Component Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
